Skip to main content
SpringerLink
Log in

Prostate cancer

Identifying sites of recurrence with choline-PET–CT imaging

  • News & Views
  • Published:

From Nature Reviews Urology

View current issue Sign up to alerts

Management of biochemically recurrent prostate cancer can be determined by the use of nomograms based on risk factors, but this approach might not lead to selection of optimal courses of treatment for individual patients. Choline-PET–CT imaging can identify the sites of recurrence in these patients, enabling personalized treatment choices depending on the presence of localized or metastatic disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Goldstein, J. et al. Does choline PET/CT change the management of prostate cancer patients with biochemical failure? Am. J. Clin. Oncol. http://dx.doi.org/10.1097/COC.0000000000000139.

  2. Kattan, M. W., Wheeler, T. M. & Scardino, P. T. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J. Clin. Oncol. 17, 1499–1507 (1999).

    Article  CAS  Google Scholar 

  3. Mohler, J. L. et al. Prostate cancer, version 1.2014. J. Natl Compr. Canc. Netw. 11, 1471–1479 (2013).

    Article  CAS  Google Scholar 

  4. Heidenreich, A. et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur. Urol. 65, 467–479 (2014).

    CAS  PubMed  Google Scholar 

  5. Berkovic, P. et al. Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy. Clin. Genitourin. Cancer 11, 27–32 (2013).

    Article  Google Scholar 

  6. Suardi, N. et al. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2014.02.011.

  7. Castellucci, P. et al. Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy? J. Nucl. Med. 55, 1424–1429 (2014).

    Article  CAS  Google Scholar 

  8. Soyka, J. D. et al. Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer. Eur. J. Nucl. Med. Mol. Imaging 39, 936–943 (2012).

    Article  CAS  Google Scholar 

  9. Ceci, F. et al. Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial. Eur. J. Nucl. Med. Mol. Imaging http://dx.doi.org/10.1007/s00259-014-2872-x.

Download references

Author information

Authors and Affiliations

  1. Service of Nuclear Medicine, Policlinico S. Orsola-Malpighi, University of Bologna, Via Massarenti 9, Bologna, 40138, Italy

    Paolo Castellucci & Stefano Fanti

Authors
  1. Paolo Castellucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefano Fanti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Castellucci.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Castellucci, P., Fanti, S. Identifying sites of recurrence with choline-PET–CT imaging. Nat Rev Urol 12, 134–135 (2015). https://doi.org/10.1038/nrurol.2014.321

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2014.321

  • Springer Nature Limited

This article is cited by

Search

Navigation